SPL 2.11% 9.3¢ starpharma holdings limited

Ann: DEP irinotecan phase 2 commences after positive phase 1, page-9

  1. 1,725 Posts.
    lightbulb Created with Sketch. 536
    Excellent result.
    DEP will be a success and depending on the levels it reaches will be a huge money earner for the Company.
    Level 1 is the reduced side effects.
    Level 2 is the days/months/years of extra life it gives the cancer patients.
    Level 3 is if DEP can actually defeat some of these very nasty cancers.
    I dont need to tell you how the Company will be valued if we hit level 3.


 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.3¢
Change
-0.002(2.11%)
Mkt cap ! $38.35M
Open High Low Value Volume
9.5¢ 9.5¢ 9.3¢ $48.64K 512.2K

Buyers (Bids)

No. Vol. Price($)
3 153365 9.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.8¢ 65000 1
View Market Depth
Last trade - 16.10pm 02/08/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.